Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug 12;24(1):918.
doi: 10.1186/s12913-024-11340-1.

Detection and management of localized prostate cancer in Nigeria: barriers and facilitators according to patients, caregivers and healthcare providers

Affiliations

Detection and management of localized prostate cancer in Nigeria: barriers and facilitators according to patients, caregivers and healthcare providers

Musliu Adetola Tolani et al. BMC Health Serv Res. .

Abstract

Background: Prostate cancer mortality rates are high in Nigeria. While prostate cancer is highly curable with early detection and effective multidisciplinary management, the quality of care is suboptimal in this setting. Sustainable delivery of high-quality care for patients with localized prostate cancer is needed to save more lives. To inform future interventions to improve care, this study aimed to identify barriers and facilitators that influence prostate cancer detection and management in Nigeria.

Methods: Six focus group discussions (FGDs), stratified by stakeholders were conducted with a purposive sample of prostate cancer patients (n = 19), caregivers (n = 15), and healthcare providers (n = 18), in two academic tertiary hospitals in northern and southern Nigeria. A discussion guide organized based on the socio-ecological model was used. FGDs were recorded, transcribed, and analysed using the framework technique.

Results: Barriers and facilitators were identified at the individual, interpersonal, and organizational levels. Barriers to detection included limited knowledge and misperceptions among patients, caregivers, and community-based non-specialist healthcare providers, and limitations of centralized opportunistic screening; while facilitators included the potential for religious institutions to encourage positive health-seeking behaviour. Barriers to management included non-uniformity in clinical guideline usage, treatment abandonment amidst concerns about treatment and survival, absence of patient interaction platforms and follow-up support systems, difficulty in navigating service areas, low health insurance coverage and limited financial resource of patients. Facilitators of management included the availability of resource stratified guidelines for prostate cancer management and the availability of patient peers, caregivers, nurses, and medical social workers to provide correct medical information and support patient-centred services. Participants also provided suggestions that could help improve prostate cancer detection and management in Nigeria.

Conclusion: This study identified multiple determinants affecting the detection and management of localized prostate cancer. These findings will inform the refinement of implementation strategies to improve the quality of prostate cancer care in Nigeria.

Keywords: Delivery of health care; Health services accessibility; Needs assessment; Nigeria; Prostatic neoplasms; Qualitative research.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Barriers and facilitators to localized prostate cancer detection and management at the individual level
Fig. 2
Fig. 2
Barriers and facilitators to localized prostate cancer detection and management at the interpersonal level
Fig. 3
Fig. 3
Barriers and facilitators to localized prostate cancer detection and management at the organizational level

Similar articles

Cited by

References

    1. Nigerian National System of Cancer Registries. Cancer incidence in Nigeria: GLOBOCAN 2012 report. Newsl Nigerian Natl Syst Cancer Registries. 2014;1–10.
    1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49. 10.3322/caac.21660 - DOI - PubMed
    1. Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M et al. Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. 2020. pp. 1–2. https://gco.iarc.fr/today/data/factsheets/cancers/27-Prostate-fact-sheet....
    1. Klein EA. Prostate cancer: Risk stratification and choice of initial treatment. Up To Date. 2021 [cited 2021 Apr 7]. pp. 1–31. https://www.uptodate.com/contents/prostate-cancer-risk-stratification-an... Localized prostate cancer&source = search_result&selectedTitle = 7 ~ 150&usage_type = default&display_rank = 7.
    1. Federal Ministry of Health. National Cancer Control Plan 2018–2022. 1st ed. Abuja, Nigeria: Federal Ministry of Health; 2022. pp. 1–67.